Thursday, June 25, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 858 of 1,261
  1. US 8506928

    Methods and compounds for targeting tissues

    The Regents of the University of California · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  2. US 8507445

    Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer

    The Board of Regents of the University of Texas System · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  3. US 8507437

    Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  4. US 8507206

    Monoclonal antibodies that target pathological assemblies of amyloid β (Abeta)

    Acumen Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  5. US 8507433

    Cardioprotective effects of GHRH agonists

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  6. EP 2623110

    Faktor-XII-Hemmer zur Behandlung neurologischer Entzündungserkrankungen

    CSL BEHRING GMBH [DE] · Granted Aug 7, 2013 · Expires Aug 2, 2033

    granted
  7. US 8501926

    Malaria vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  8. US 8501920

    Nucleic acid sequences encoding peptides with utrophin spectrin-like repeats

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  9. US 8501804

    Bicyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  10. US 8501798

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  11. US 8501953

    PKM2 modulators for use in the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  12. US 8501182

    Monoclonal antibodies that react with the capsule of Bacillus anthracis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  13. US 8501184

    High affinity human antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  14. US 8501247

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  15. US 8501446

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  16. US 8501964

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  17. US 8501776

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  18. US 8501686

    Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  19. BR PI0714667

    conjugado molecular e respectivo uso

    CERAMOPTEC IND INC [US] · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  20. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  21. US 8501803

    Garcinia derivative, its preparing method and medicinal use

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  22. US 8501899

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  23. US 8501912

    Filipil compositions and methods for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  24. US 8501905

    Synthetic cell platforms and methods of use thereof

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.